Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -29.61% vs 6.45% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 1,013.54% vs -1.03% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 50.19% vs 42.06% in Mar 2025
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.51
10.25
-1.74
-16.98%
Share Warrants & Outstandings
Total Reserve
30.35
130.22
-99.87
-76.69%
Shareholder's Funds
38.86
140.47
-101.61
-72.34%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.55
0.00
3.55
0.00%
Secured Loans
3.17
0.00
3.17
0.00%
Unsecured Loans
0.38
0.00
0.38
0.00%
Deferred Tax Assets / Liabilities
0.08
1.01
-0.93
-92.08%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
3.79
1.01
2.78
275.25%
Current Liabilities
Trade Payables
5.76
2.50
3.26
130.40%
Other Current Liabilities
1.68
4.05
-2.37
-58.52%
Short Term Borrowings
1.55
0.00
1.55
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
8.99
6.56
2.43
37.04%
Total Liabilities
51.65
148.04
-96.39
-65.11%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11.05
49.45
-38.40
-77.65%
Less: Accumulated Depreciation
0.36
30.57
-30.21
-98.82%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.69
18.88
-8.19
-43.38%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.38
1.12
-0.74
-66.07%
Other Non Current Assets
0.00
20.09
-20.09
-100.00%
Total Non-Current Assets
11.07
40.10
-29.03
-72.39%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.77
9.92
-9.15
-92.24%
Sundry Debtors
36.57
19.54
17.03
87.15%
Cash and Bank
1.29
75.32
-74.03
-98.29%
Other Current Assets
0.00
2.55
-2.55
-100.00%
Short Term Loans and Advances
1.95
0.62
1.33
214.52%
Total Current Assets
40.58
107.95
-67.37
-62.41%
Net Current Assets (Including Current Investments)
31.59
101.39
-69.80
-68.84%
Total Current Assets Excluding Current Investments
40.58
107.95
-67.37
-62.41%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
51.65
148.04
-96.39
-65.11%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
5.11
0.00
5.11
0.00%
Book Value per share (adjusted)
45.65
137.11
-91.46
-66.71%
Annual - Borrowings
Borrowings 5.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -29.61% vs 6.45% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.69 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1,013.54% vs -1.03% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 40.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 50.19% vs 42.06% in Mar 2025
